Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization

Bulletin of Experimental Biology and Medicine

Volumn 147, Issue 4, 2009, Pages 448-452

  Olovnikova, N I ^a   Ershler, M A ^a   Belkina, E V ^a   Nikolaeva, T L ^a   Miterev, G Yu ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Antibody dependent cytotoxicity; D antigen; Fc receptor; Immunosuppression; Monoclonal antibodies

Indexed keywords

CD16 ANTIGEN; FC RECEPTOR IIA; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3; RHESUS D ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BLOOD GROUP RHESUS SYSTEM; CELL FUSION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEMOLYSIS; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; IMMUNOPROPHYLAXIS; MOUSE; MYELOMA CELL; NONHUMAN; RAT; RHESUS ISOIMMUNIZATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; B-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; ERYTHROCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; ISOANTIBODIES; LYMPHOCYTES; MICE; MONOCYTES; RATS; RECEPTORS, IGG; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

RATTUS; RODENTIA;

EID: 70349140027     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0516-0     Document Type: Article

References (15)

1. N. I. Olovnikova, E. V. Belkina, N. I. Drize, et al., Bull. Exp. Biol. Med., 129, No. 1, 77-81 (2000).
2. N. I. Olovnikova, E. V. Belkina, T. L. Nikolaeva, et al., Ibid., 141, No. 1, 63-67 (2006).
3. R. Beliard, T. Waegemans, D. Notelet, et al., Br. J. Haematol., 141, No. 1, 109-119 (2008).
4. R. Clynes, Curr. Opin. Immunol., 19, No. 6, 646-651 (2007).
5. T. Ducrot, R. Beliard, A. Glacet, et al., Vox Sang., 71, No. 1, 30-36 (1996).
6. C. P. Engelfriet, M. A. Overbeeke, M. C. Dooren, et al., Transfusion, 34, No. 7, 617-626 (1994).
7. F. Hjelm, F. Carlsson, A. Getahun, and B. Heyman, Scand. J. Immunol., 64, No. 3, 177-184 (2006).
8. Y. Kanda, N. Yamane-Ohnuki, N. Sakai, et al., Biotechnol. Bioeng., 94, No. 4, 680-688 (2006).
9. B. M. Kumpel, Transfus. Clin Biol., 9, No. 1, 9-14 (2002).
10. B. M. Kumpel, Vox Sang, 93, No. 2, 99-111 (2007).
11. T. Paterson, J. Innes, L. McMillan, et al., Immunotechnology, 4, No. 1, 37-47 (1998).
12. S. Radaev and P.D. Sun, J. Biol. Chem., 276, No. 19, 16,478-16,483 (2001).
13. T. S. Raju, J. B. Briggs, S. M. Borge, and A. J. Jones, Glycobiology, 10, No. 5, 477-486 (2000).
14. T. Shinkawa, K. Nakamura, N. Yamane, et al., J. Biol. Chem, 278, No. 5, 3466-3473 (2003).
15. M. Tandai, T. Endo, S. Sasaki, et al., Arch. Biochem. Biophys., 91, No. 2, 339-348 (1991).